After PSM, the two groups did not differ significantly in age, BMI, smoking status, diabetes, tumor size, lymph node status, type of cancer, hormone receptor status, ERBB2 status, preoperative chemotherapy, postoperative chemotherapy, or lymph node surgery. This evidence concerns the gene NR4A1 and cancer.